Evidence map›Paper›PMID 19812036›Full record

ArticleThe Journal of biological chemistry2009

Double superhelix model of high density lipoprotein.

Zhiping Wu, Valentin Gogonea, Xavier Lee, Matthew A Wagner, Xin-Min Li, Ying Huang, Arundhati Undurti, Roland P May, Michael Haertlein, Martine Moulin and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Molecular dynamics simulations of lipid nanodiscs.Biochimica et biophysica acta. Biomembranes · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Zhiping WuDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Valentin GogoneaDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Department of Chemistry, Cleveland State University, Cleveland, Ohio 44115.
Xavier LeeDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Matthew A WagnerDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Xin-Min LiDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Ying HuangDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Arundhati UndurtiDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Roland P MayInstitut Laue-Langevin, 6 Rue Jules Horowitz, BP 156, 38042 Grenoble Cedex 9, France.
Michael HaertleinInstitut Laue-Langevin, 6 Rue Jules Horowitz, BP 156, 38042 Grenoble Cedex 9, France.
Martine MoulinInstitut Laue-Langevin, 6 Rue Jules Horowitz, BP 156, 38042 Grenoble Cedex 9, France.
Irina GutscheUnit of Virus-Host Interaction, Unité Mixte de Recherche 5233 Université Joseph Fourier-European Molecular Biology Laboratory-CNRS, 6 Rue Jules Horowitz, BP 181, 38042 Grenoble Cedex 9, France.
Giuseppe ZaccaiInstitut Laue-Langevin, 6 Rue Jules Horowitz, BP 156, 38042 Grenoble Cedex 9, France; Institut de Biologie Structurale, Commissariat à l'Energie Atomique-CNRS-Université Joseph Fourier, 38027 Grenoble, France.
Joseph A DiDonatoDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195.
Stanley L HazenDepartment of Cell Biology, Cleveland Clinic, Cleveland, Ohio 44195; Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, Ohio 44195; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195. Electronic address: hazens@ccf.org.
Cleveland Clinic · USInstitut Laue-Langevin · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FREuropean Molecular Biology Laboratory · FR

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Structural Determinants Of Ceruloplasmin Inflammatory ActivityP01HL076491 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI GOGONEA, VALENTIN · 2004 to 2019
$27.3M
The Role of Thrombospondins in AtherothrombosisP50HL077107 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 2005 to 2009
$16.5M
REGULATION OF MONOCYTE 15-LIPOXYGENASE EXPRESSIONP01HL087018 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MCINTYRE, THOMAS M · 2007 to 2011
$11.4M
Case Western Reserve University/Cleveland Clinic CTSA (KL2)KL2RR024990 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$9.5M
Arg199: key player in electron transfer in NOS enzymeR15GM070469 · NIGMS · CLEVELAND STATE UNIVERSITY · PI GOGONEA, VALENTIN · 2004 to 2004
$211k
NCRR NIH HHS 1KL2RR024990NCRR NIH HHS KL2 RR024990NHLBI NIH HHS P01 HL076491-055328NHLBI NIH HHS P01 HL077107-050004NHLBI NIH HHS P01 HL087018-02001NIGMS NIH HHS 1R15 GM070469-01NIGMS NIH HHS R15 GM070469NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

High density lipoprotein (HDL), the carrier of so-called "good" cholesterol, serves as the major athero-protective lipoprotein and has emerged as a key therapeutic target for cardiovascular disease. We applied small angle neutron scattering (SANS) with contrast variation and selective isotopic deuteration to the study of nascent HDL to obtain the low resolution structure in solution of the overall time-averaged conformation of apolipoprotein AI (apoA-I) versus the lipid (acyl chain) core of the particle. Remarkably, apoA-I is observed to possess an open helical shape that wraps around a central ellipsoidal lipid phase. Using the low resolution SANS shapes of the protein and lipid core as scaffolding, an all-atom computational model for the protein and lipid components of nascent HDL was developed by integrating complementary structural data from hydrogen/deuterium exchange mass spectrometry and previously published constraints from multiple biophysical techniques. Both SANS data and the new computational model, the double superhelix model, suggest an unexpected structural arrangement of protein and lipids of nascent HDL, an anti-parallel double superhelix wrapped around an ellipsoidal lipid phase. The protein and lipid organization in nascent HDL envisages a potential generalized mechanism for lipoprotein biogenesis and remodeling, biological processes critical to sterol and lipid transport, organismal energy metabolism, and innate immunity.

Indexed as

Models, MolecularApolipoprotein A-IBiological TransportHumansLipid MetabolismLipidsLipoproteins, HDLProtein Structure, QuaternaryProtein Structure, SecondaryApolipoprotein A-ILipidsLipoproteins, HDL

Identifiers

PMID19812036
PMCPMC2794775
OpenAlexW2121774886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.